Pharma & Healthcare
Global Opioids Agonist Drugs Market Research Report 2025
- Sep 09, 25
- ID: 496998
- Pages: 87
- Figures: 84
- Views: 5
This report aims to provide a comprehensive presentation of the global market for Opioids Agonist Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Opioids Agonist Drugs.
The Opioids Agonist Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Opioids Agonist Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Opioids Agonist Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Purdue Pharma
Titan pharmaceuticals
Boehringer Ingelheim
Janssen Pharmaceuticals, Inc
Sanofi
Sun Pharmaceuticals
Mallinckrodt Pharmaceuticals
Egalet Corporation
Endo Pharmaceuticals Inc.
Allergan, Plc
Pfizer Inc
Johnson & Johnson Services, Inc.
Hikma Pharmaceuticals PLC
Grünenthal
AbbVie Inc.
Segment by Type
Codeine
Fentanyl
Meperidine
Methadone
Morphine
Hydrocodone
Segment by Application
Pain Management
Cough Treatment
Diarrhea Treatment
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Opioids Agonist Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Opioids Agonist Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Opioids Agonist Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Opioids Agonist Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Purdue Pharma
Titan pharmaceuticals
Boehringer Ingelheim
Janssen Pharmaceuticals, Inc
Sanofi
Sun Pharmaceuticals
Mallinckrodt Pharmaceuticals
Egalet Corporation
Endo Pharmaceuticals Inc.
Allergan, Plc
Pfizer Inc
Johnson & Johnson Services, Inc.
Hikma Pharmaceuticals PLC
Grünenthal
AbbVie Inc.
Segment by Type
Codeine
Fentanyl
Meperidine
Methadone
Morphine
Hydrocodone
Segment by Application
Pain Management
Cough Treatment
Diarrhea Treatment
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Opioids Agonist Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Opioids Agonist Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Codeine
1.2.3 Fentanyl
1.2.4 Meperidine
1.2.5 Methadone
1.2.6 Morphine
1.2.7 Hydrocodone
1.3 Market by Application
1.3.1 Global Opioids Agonist Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pain Management
1.3.3 Cough Treatment
1.3.4 Diarrhea Treatment
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Opioids Agonist Drugs Market Perspective (2020-2031)
2.2 Global Opioids Agonist Drugs Growth Trends by Region
2.2.1 Global Opioids Agonist Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Opioids Agonist Drugs Historic Market Size by Region (2020-2025)
2.2.3 Opioids Agonist Drugs Forecasted Market Size by Region (2026-2031)
2.3 Opioids Agonist Drugs Market Dynamics
2.3.1 Opioids Agonist Drugs Industry Trends
2.3.2 Opioids Agonist Drugs Market Drivers
2.3.3 Opioids Agonist Drugs Market Challenges
2.3.4 Opioids Agonist Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Opioids Agonist Drugs Players by Revenue
3.1.1 Global Top Opioids Agonist Drugs Players by Revenue (2020-2025)
3.1.2 Global Opioids Agonist Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Opioids Agonist Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Opioids Agonist Drugs Revenue
3.4 Global Opioids Agonist Drugs Market Concentration Ratio
3.4.1 Global Opioids Agonist Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Opioids Agonist Drugs Revenue in 2024
3.5 Global Key Players of Opioids Agonist Drugs Head office and Area Served
3.6 Global Key Players of Opioids Agonist Drugs, Product and Application
3.7 Global Key Players of Opioids Agonist Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Opioids Agonist Drugs Breakdown Data by Type
4.1 Global Opioids Agonist Drugs Historic Market Size by Type (2020-2025)
4.2 Global Opioids Agonist Drugs Forecasted Market Size by Type (2026-2031)
5 Opioids Agonist Drugs Breakdown Data by Application
5.1 Global Opioids Agonist Drugs Historic Market Size by Application (2020-2025)
5.2 Global Opioids Agonist Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Opioids Agonist Drugs Market Size (2020-2031)
6.2 North America Opioids Agonist Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Opioids Agonist Drugs Market Size by Country (2020-2025)
6.4 North America Opioids Agonist Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Opioids Agonist Drugs Market Size (2020-2031)
7.2 Europe Opioids Agonist Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Opioids Agonist Drugs Market Size by Country (2020-2025)
7.4 Europe Opioids Agonist Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Opioids Agonist Drugs Market Size (2020-2031)
8.2 Asia-Pacific Opioids Agonist Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Opioids Agonist Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Opioids Agonist Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Opioids Agonist Drugs Market Size (2020-2031)
9.2 Latin America Opioids Agonist Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Opioids Agonist Drugs Market Size by Country (2020-2025)
9.4 Latin America Opioids Agonist Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Opioids Agonist Drugs Market Size (2020-2031)
10.2 Middle East & Africa Opioids Agonist Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Opioids Agonist Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Opioids Agonist Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Purdue Pharma
11.1.1 Purdue Pharma Company Details
11.1.2 Purdue Pharma Business Overview
11.1.3 Purdue Pharma Opioids Agonist Drugs Introduction
11.1.4 Purdue Pharma Revenue in Opioids Agonist Drugs Business (2020-2025)
11.1.5 Purdue Pharma Recent Development
11.2 Titan pharmaceuticals
11.2.1 Titan pharmaceuticals Company Details
11.2.2 Titan pharmaceuticals Business Overview
11.2.3 Titan pharmaceuticals Opioids Agonist Drugs Introduction
11.2.4 Titan pharmaceuticals Revenue in Opioids Agonist Drugs Business (2020-2025)
11.2.5 Titan pharmaceuticals Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Details
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Opioids Agonist Drugs Introduction
11.3.4 Boehringer Ingelheim Revenue in Opioids Agonist Drugs Business (2020-2025)
11.3.5 Boehringer Ingelheim Recent Development
11.4 Janssen Pharmaceuticals, Inc
11.4.1 Janssen Pharmaceuticals, Inc Company Details
11.4.2 Janssen Pharmaceuticals, Inc Business Overview
11.4.3 Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Introduction
11.4.4 Janssen Pharmaceuticals, Inc Revenue in Opioids Agonist Drugs Business (2020-2025)
11.4.5 Janssen Pharmaceuticals, Inc Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Opioids Agonist Drugs Introduction
11.5.4 Sanofi Revenue in Opioids Agonist Drugs Business (2020-2025)
11.5.5 Sanofi Recent Development
11.6 Sun Pharmaceuticals
11.6.1 Sun Pharmaceuticals Company Details
11.6.2 Sun Pharmaceuticals Business Overview
11.6.3 Sun Pharmaceuticals Opioids Agonist Drugs Introduction
11.6.4 Sun Pharmaceuticals Revenue in Opioids Agonist Drugs Business (2020-2025)
11.6.5 Sun Pharmaceuticals Recent Development
11.7 Mallinckrodt Pharmaceuticals
11.7.1 Mallinckrodt Pharmaceuticals Company Details
11.7.2 Mallinckrodt Pharmaceuticals Business Overview
11.7.3 Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Introduction
11.7.4 Mallinckrodt Pharmaceuticals Revenue in Opioids Agonist Drugs Business (2020-2025)
11.7.5 Mallinckrodt Pharmaceuticals Recent Development
11.8 Egalet Corporation
11.8.1 Egalet Corporation Company Details
11.8.2 Egalet Corporation Business Overview
11.8.3 Egalet Corporation Opioids Agonist Drugs Introduction
11.8.4 Egalet Corporation Revenue in Opioids Agonist Drugs Business (2020-2025)
11.8.5 Egalet Corporation Recent Development
11.9 Endo Pharmaceuticals Inc.
11.9.1 Endo Pharmaceuticals Inc. Company Details
11.9.2 Endo Pharmaceuticals Inc. Business Overview
11.9.3 Endo Pharmaceuticals Inc. Opioids Agonist Drugs Introduction
11.9.4 Endo Pharmaceuticals Inc. Revenue in Opioids Agonist Drugs Business (2020-2025)
11.9.5 Endo Pharmaceuticals Inc. Recent Development
11.10 Allergan, Plc
11.10.1 Allergan, Plc Company Details
11.10.2 Allergan, Plc Business Overview
11.10.3 Allergan, Plc Opioids Agonist Drugs Introduction
11.10.4 Allergan, Plc Revenue in Opioids Agonist Drugs Business (2020-2025)
11.10.5 Allergan, Plc Recent Development
11.11 Pfizer Inc
11.11.1 Pfizer Inc Company Details
11.11.2 Pfizer Inc Business Overview
11.11.3 Pfizer Inc Opioids Agonist Drugs Introduction
11.11.4 Pfizer Inc Revenue in Opioids Agonist Drugs Business (2020-2025)
11.11.5 Pfizer Inc Recent Development
11.12 Johnson & Johnson Services, Inc.
11.12.1 Johnson & Johnson Services, Inc. Company Details
11.12.2 Johnson & Johnson Services, Inc. Business Overview
11.12.3 Johnson & Johnson Services, Inc. Opioids Agonist Drugs Introduction
11.12.4 Johnson & Johnson Services, Inc. Revenue in Opioids Agonist Drugs Business (2020-2025)
11.12.5 Johnson & Johnson Services, Inc. Recent Development
11.13 Hikma Pharmaceuticals PLC
11.13.1 Hikma Pharmaceuticals PLC Company Details
11.13.2 Hikma Pharmaceuticals PLC Business Overview
11.13.3 Hikma Pharmaceuticals PLC Opioids Agonist Drugs Introduction
11.13.4 Hikma Pharmaceuticals PLC Revenue in Opioids Agonist Drugs Business (2020-2025)
11.13.5 Hikma Pharmaceuticals PLC Recent Development
11.14 Grünenthal
11.14.1 Grünenthal Company Details
11.14.2 Grünenthal Business Overview
11.14.3 Grünenthal Opioids Agonist Drugs Introduction
11.14.4 Grünenthal Revenue in Opioids Agonist Drugs Business (2020-2025)
11.14.5 Grünenthal Recent Development
11.15 AbbVie Inc.
11.15.1 AbbVie Inc. Company Details
11.15.2 AbbVie Inc. Business Overview
11.15.3 AbbVie Inc. Opioids Agonist Drugs Introduction
11.15.4 AbbVie Inc. Revenue in Opioids Agonist Drugs Business (2020-2025)
11.15.5 AbbVie Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Opioids Agonist Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Codeine
1.2.3 Fentanyl
1.2.4 Meperidine
1.2.5 Methadone
1.2.6 Morphine
1.2.7 Hydrocodone
1.3 Market by Application
1.3.1 Global Opioids Agonist Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pain Management
1.3.3 Cough Treatment
1.3.4 Diarrhea Treatment
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Opioids Agonist Drugs Market Perspective (2020-2031)
2.2 Global Opioids Agonist Drugs Growth Trends by Region
2.2.1 Global Opioids Agonist Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Opioids Agonist Drugs Historic Market Size by Region (2020-2025)
2.2.3 Opioids Agonist Drugs Forecasted Market Size by Region (2026-2031)
2.3 Opioids Agonist Drugs Market Dynamics
2.3.1 Opioids Agonist Drugs Industry Trends
2.3.2 Opioids Agonist Drugs Market Drivers
2.3.3 Opioids Agonist Drugs Market Challenges
2.3.4 Opioids Agonist Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Opioids Agonist Drugs Players by Revenue
3.1.1 Global Top Opioids Agonist Drugs Players by Revenue (2020-2025)
3.1.2 Global Opioids Agonist Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Opioids Agonist Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Opioids Agonist Drugs Revenue
3.4 Global Opioids Agonist Drugs Market Concentration Ratio
3.4.1 Global Opioids Agonist Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Opioids Agonist Drugs Revenue in 2024
3.5 Global Key Players of Opioids Agonist Drugs Head office and Area Served
3.6 Global Key Players of Opioids Agonist Drugs, Product and Application
3.7 Global Key Players of Opioids Agonist Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Opioids Agonist Drugs Breakdown Data by Type
4.1 Global Opioids Agonist Drugs Historic Market Size by Type (2020-2025)
4.2 Global Opioids Agonist Drugs Forecasted Market Size by Type (2026-2031)
5 Opioids Agonist Drugs Breakdown Data by Application
5.1 Global Opioids Agonist Drugs Historic Market Size by Application (2020-2025)
5.2 Global Opioids Agonist Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Opioids Agonist Drugs Market Size (2020-2031)
6.2 North America Opioids Agonist Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Opioids Agonist Drugs Market Size by Country (2020-2025)
6.4 North America Opioids Agonist Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Opioids Agonist Drugs Market Size (2020-2031)
7.2 Europe Opioids Agonist Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Opioids Agonist Drugs Market Size by Country (2020-2025)
7.4 Europe Opioids Agonist Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Opioids Agonist Drugs Market Size (2020-2031)
8.2 Asia-Pacific Opioids Agonist Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Opioids Agonist Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Opioids Agonist Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Opioids Agonist Drugs Market Size (2020-2031)
9.2 Latin America Opioids Agonist Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Opioids Agonist Drugs Market Size by Country (2020-2025)
9.4 Latin America Opioids Agonist Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Opioids Agonist Drugs Market Size (2020-2031)
10.2 Middle East & Africa Opioids Agonist Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Opioids Agonist Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Opioids Agonist Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Purdue Pharma
11.1.1 Purdue Pharma Company Details
11.1.2 Purdue Pharma Business Overview
11.1.3 Purdue Pharma Opioids Agonist Drugs Introduction
11.1.4 Purdue Pharma Revenue in Opioids Agonist Drugs Business (2020-2025)
11.1.5 Purdue Pharma Recent Development
11.2 Titan pharmaceuticals
11.2.1 Titan pharmaceuticals Company Details
11.2.2 Titan pharmaceuticals Business Overview
11.2.3 Titan pharmaceuticals Opioids Agonist Drugs Introduction
11.2.4 Titan pharmaceuticals Revenue in Opioids Agonist Drugs Business (2020-2025)
11.2.5 Titan pharmaceuticals Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Details
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Opioids Agonist Drugs Introduction
11.3.4 Boehringer Ingelheim Revenue in Opioids Agonist Drugs Business (2020-2025)
11.3.5 Boehringer Ingelheim Recent Development
11.4 Janssen Pharmaceuticals, Inc
11.4.1 Janssen Pharmaceuticals, Inc Company Details
11.4.2 Janssen Pharmaceuticals, Inc Business Overview
11.4.3 Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Introduction
11.4.4 Janssen Pharmaceuticals, Inc Revenue in Opioids Agonist Drugs Business (2020-2025)
11.4.5 Janssen Pharmaceuticals, Inc Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Opioids Agonist Drugs Introduction
11.5.4 Sanofi Revenue in Opioids Agonist Drugs Business (2020-2025)
11.5.5 Sanofi Recent Development
11.6 Sun Pharmaceuticals
11.6.1 Sun Pharmaceuticals Company Details
11.6.2 Sun Pharmaceuticals Business Overview
11.6.3 Sun Pharmaceuticals Opioids Agonist Drugs Introduction
11.6.4 Sun Pharmaceuticals Revenue in Opioids Agonist Drugs Business (2020-2025)
11.6.5 Sun Pharmaceuticals Recent Development
11.7 Mallinckrodt Pharmaceuticals
11.7.1 Mallinckrodt Pharmaceuticals Company Details
11.7.2 Mallinckrodt Pharmaceuticals Business Overview
11.7.3 Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Introduction
11.7.4 Mallinckrodt Pharmaceuticals Revenue in Opioids Agonist Drugs Business (2020-2025)
11.7.5 Mallinckrodt Pharmaceuticals Recent Development
11.8 Egalet Corporation
11.8.1 Egalet Corporation Company Details
11.8.2 Egalet Corporation Business Overview
11.8.3 Egalet Corporation Opioids Agonist Drugs Introduction
11.8.4 Egalet Corporation Revenue in Opioids Agonist Drugs Business (2020-2025)
11.8.5 Egalet Corporation Recent Development
11.9 Endo Pharmaceuticals Inc.
11.9.1 Endo Pharmaceuticals Inc. Company Details
11.9.2 Endo Pharmaceuticals Inc. Business Overview
11.9.3 Endo Pharmaceuticals Inc. Opioids Agonist Drugs Introduction
11.9.4 Endo Pharmaceuticals Inc. Revenue in Opioids Agonist Drugs Business (2020-2025)
11.9.5 Endo Pharmaceuticals Inc. Recent Development
11.10 Allergan, Plc
11.10.1 Allergan, Plc Company Details
11.10.2 Allergan, Plc Business Overview
11.10.3 Allergan, Plc Opioids Agonist Drugs Introduction
11.10.4 Allergan, Plc Revenue in Opioids Agonist Drugs Business (2020-2025)
11.10.5 Allergan, Plc Recent Development
11.11 Pfizer Inc
11.11.1 Pfizer Inc Company Details
11.11.2 Pfizer Inc Business Overview
11.11.3 Pfizer Inc Opioids Agonist Drugs Introduction
11.11.4 Pfizer Inc Revenue in Opioids Agonist Drugs Business (2020-2025)
11.11.5 Pfizer Inc Recent Development
11.12 Johnson & Johnson Services, Inc.
11.12.1 Johnson & Johnson Services, Inc. Company Details
11.12.2 Johnson & Johnson Services, Inc. Business Overview
11.12.3 Johnson & Johnson Services, Inc. Opioids Agonist Drugs Introduction
11.12.4 Johnson & Johnson Services, Inc. Revenue in Opioids Agonist Drugs Business (2020-2025)
11.12.5 Johnson & Johnson Services, Inc. Recent Development
11.13 Hikma Pharmaceuticals PLC
11.13.1 Hikma Pharmaceuticals PLC Company Details
11.13.2 Hikma Pharmaceuticals PLC Business Overview
11.13.3 Hikma Pharmaceuticals PLC Opioids Agonist Drugs Introduction
11.13.4 Hikma Pharmaceuticals PLC Revenue in Opioids Agonist Drugs Business (2020-2025)
11.13.5 Hikma Pharmaceuticals PLC Recent Development
11.14 Grünenthal
11.14.1 Grünenthal Company Details
11.14.2 Grünenthal Business Overview
11.14.3 Grünenthal Opioids Agonist Drugs Introduction
11.14.4 Grünenthal Revenue in Opioids Agonist Drugs Business (2020-2025)
11.14.5 Grünenthal Recent Development
11.15 AbbVie Inc.
11.15.1 AbbVie Inc. Company Details
11.15.2 AbbVie Inc. Business Overview
11.15.3 AbbVie Inc. Opioids Agonist Drugs Introduction
11.15.4 AbbVie Inc. Revenue in Opioids Agonist Drugs Business (2020-2025)
11.15.5 AbbVie Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Opioids Agonist Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Codeine
Table 3. Key Players of Fentanyl
Table 4. Key Players of Meperidine
Table 5. Key Players of Methadone
Table 6. Key Players of Morphine
Table 7. Key Players of Hydrocodone
Table 8. Global Opioids Agonist Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Opioids Agonist Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Opioids Agonist Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 11. Global Opioids Agonist Drugs Market Share by Region (2020-2025)
Table 12. Global Opioids Agonist Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 13. Global Opioids Agonist Drugs Market Share by Region (2026-2031)
Table 14. Opioids Agonist Drugs Market Trends
Table 15. Opioids Agonist Drugs Market Drivers
Table 16. Opioids Agonist Drugs Market Challenges
Table 17. Opioids Agonist Drugs Market Restraints
Table 18. Global Opioids Agonist Drugs Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Opioids Agonist Drugs Market Share by Players (2020-2025)
Table 20. Global Top Opioids Agonist Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioids Agonist Drugs as of 2024)
Table 21. Ranking of Global Top Opioids Agonist Drugs Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Opioids Agonist Drugs Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Opioids Agonist Drugs, Headquarters and Area Served
Table 24. Global Key Players of Opioids Agonist Drugs, Product and Application
Table 25. Global Key Players of Opioids Agonist Drugs, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Opioids Agonist Drugs Market Size by Type (2020-2025) & (US$ Million)
Table 28. Global Opioids Agonist Drugs Revenue Market Share by Type (2020-2025)
Table 29. Global Opioids Agonist Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 30. Global Opioids Agonist Drugs Revenue Market Share by Type (2026-2031)
Table 31. Global Opioids Agonist Drugs Market Size by Application (2020-2025) & (US$ Million)
Table 32. Global Opioids Agonist Drugs Revenue Market Share by Application (2020-2025)
Table 33. Global Opioids Agonist Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 34. Global Opioids Agonist Drugs Revenue Market Share by Application (2026-2031)
Table 35. North America Opioids Agonist Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. North America Opioids Agonist Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 37. North America Opioids Agonist Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 38. Europe Opioids Agonist Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 39. Europe Opioids Agonist Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 40. Europe Opioids Agonist Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 41. Asia-Pacific Opioids Agonist Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 42. Asia-Pacific Opioids Agonist Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 43. Asia-Pacific Opioids Agonist Drugs Market Size by Region (2026-2031) & (US$ Million)
Table 44. Latin America Opioids Agonist Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Latin America Opioids Agonist Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 46. Latin America Opioids Agonist Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 47. Middle East & Africa Opioids Agonist Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 48. Middle East & Africa Opioids Agonist Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 49. Middle East & Africa Opioids Agonist Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 50. Purdue Pharma Company Details
Table 51. Purdue Pharma Business Overview
Table 52. Purdue Pharma Opioids Agonist Drugs Product
Table 53. Purdue Pharma Revenue in Opioids Agonist Drugs Business (2020-2025) & (US$ Million)
Table 54. Purdue Pharma Recent Development
Table 55. Titan pharmaceuticals Company Details
Table 56. Titan pharmaceuticals Business Overview
Table 57. Titan pharmaceuticals Opioids Agonist Drugs Product
Table 58. Titan pharmaceuticals Revenue in Opioids Agonist Drugs Business (2020-2025) & (US$ Million)
Table 59. Titan pharmaceuticals Recent Development
Table 60. Boehringer Ingelheim Company Details
Table 61. Boehringer Ingelheim Business Overview
Table 62. Boehringer Ingelheim Opioids Agonist Drugs Product
Table 63. Boehringer Ingelheim Revenue in Opioids Agonist Drugs Business (2020-2025) & (US$ Million)
Table 64. Boehringer Ingelheim Recent Development
Table 65. Janssen Pharmaceuticals, Inc Company Details
Table 66. Janssen Pharmaceuticals, Inc Business Overview
Table 67. Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Product
Table 68. Janssen Pharmaceuticals, Inc Revenue in Opioids Agonist Drugs Business (2020-2025) & (US$ Million)
Table 69. Janssen Pharmaceuticals, Inc Recent Development
Table 70. Sanofi Company Details
Table 71. Sanofi Business Overview
Table 72. Sanofi Opioids Agonist Drugs Product
Table 73. Sanofi Revenue in Opioids Agonist Drugs Business (2020-2025) & (US$ Million)
Table 74. Sanofi Recent Development
Table 75. Sun Pharmaceuticals Company Details
Table 76. Sun Pharmaceuticals Business Overview
Table 77. Sun Pharmaceuticals Opioids Agonist Drugs Product
Table 78. Sun Pharmaceuticals Revenue in Opioids Agonist Drugs Business (2020-2025) & (US$ Million)
Table 79. Sun Pharmaceuticals Recent Development
Table 80. Mallinckrodt Pharmaceuticals Company Details
Table 81. Mallinckrodt Pharmaceuticals Business Overview
Table 82. Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Product
Table 83. Mallinckrodt Pharmaceuticals Revenue in Opioids Agonist Drugs Business (2020-2025) & (US$ Million)
Table 84. Mallinckrodt Pharmaceuticals Recent Development
Table 85. Egalet Corporation Company Details
Table 86. Egalet Corporation Business Overview
Table 87. Egalet Corporation Opioids Agonist Drugs Product
Table 88. Egalet Corporation Revenue in Opioids Agonist Drugs Business (2020-2025) & (US$ Million)
Table 89. Egalet Corporation Recent Development
Table 90. Endo Pharmaceuticals Inc. Company Details
Table 91. Endo Pharmaceuticals Inc. Business Overview
Table 92. Endo Pharmaceuticals Inc. Opioids Agonist Drugs Product
Table 93. Endo Pharmaceuticals Inc. Revenue in Opioids Agonist Drugs Business (2020-2025) & (US$ Million)
Table 94. Endo Pharmaceuticals Inc. Recent Development
Table 95. Allergan, Plc Company Details
Table 96. Allergan, Plc Business Overview
Table 97. Allergan, Plc Opioids Agonist Drugs Product
Table 98. Allergan, Plc Revenue in Opioids Agonist Drugs Business (2020-2025) & (US$ Million)
Table 99. Allergan, Plc Recent Development
Table 100. Pfizer Inc Company Details
Table 101. Pfizer Inc Business Overview
Table 102. Pfizer Inc Opioids Agonist Drugs Product
Table 103. Pfizer Inc Revenue in Opioids Agonist Drugs Business (2020-2025) & (US$ Million)
Table 104. Pfizer Inc Recent Development
Table 105. Johnson & Johnson Services, Inc. Company Details
Table 106. Johnson & Johnson Services, Inc. Business Overview
Table 107. Johnson & Johnson Services, Inc. Opioids Agonist Drugs Product
Table 108. Johnson & Johnson Services, Inc. Revenue in Opioids Agonist Drugs Business (2020-2025) & (US$ Million)
Table 109. Johnson & Johnson Services, Inc. Recent Development
Table 110. Hikma Pharmaceuticals PLC Company Details
Table 111. Hikma Pharmaceuticals PLC Business Overview
Table 112. Hikma Pharmaceuticals PLC Opioids Agonist Drugs Product
Table 113. Hikma Pharmaceuticals PLC Revenue in Opioids Agonist Drugs Business (2020-2025) & (US$ Million)
Table 114. Hikma Pharmaceuticals PLC Recent Development
Table 115. Grünenthal Company Details
Table 116. Grünenthal Business Overview
Table 117. Grünenthal Opioids Agonist Drugs Product
Table 118. Grünenthal Revenue in Opioids Agonist Drugs Business (2020-2025) & (US$ Million)
Table 119. Grünenthal Recent Development
Table 120. AbbVie Inc. Company Details
Table 121. AbbVie Inc. Business Overview
Table 122. AbbVie Inc. Opioids Agonist Drugs Product
Table 123. AbbVie Inc. Revenue in Opioids Agonist Drugs Business (2020-2025) & (US$ Million)
Table 124. AbbVie Inc. Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
Table 128. Authors List of This Report
List of Figures
Figure 1. Opioids Agonist Drugs Picture
Figure 2. Global Opioids Agonist Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Opioids Agonist Drugs Market Share by Type: 2024 VS 2031
Figure 4. Codeine Features
Figure 5. Fentanyl Features
Figure 6. Meperidine Features
Figure 7. Methadone Features
Figure 8. Morphine Features
Figure 9. Hydrocodone Features
Figure 10. Global Opioids Agonist Drugs Market Size by Application (2020-2031) & (US$ Million)
Figure 11. Global Opioids Agonist Drugs Market Share by Application: 2024 VS 2031
Figure 12. Pain Management Case Studies
Figure 13. Cough Treatment Case Studies
Figure 14. Diarrhea Treatment Case Studies
Figure 15. Opioids Agonist Drugs Report Years Considered
Figure 16. Global Opioids Agonist Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global Opioids Agonist Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Opioids Agonist Drugs Market Share by Region: 2024 VS 2031
Figure 19. Global Opioids Agonist Drugs Market Share by Players in 2024
Figure 20. Global Top Opioids Agonist Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioids Agonist Drugs as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by Opioids Agonist Drugs Revenue in 2024
Figure 22. North America Opioids Agonist Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. North America Opioids Agonist Drugs Market Share by Country (2020-2031)
Figure 24. United States Opioids Agonist Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Canada Opioids Agonist Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Opioids Agonist Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Opioids Agonist Drugs Market Share by Country (2020-2031)
Figure 28. Germany Opioids Agonist Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. France Opioids Agonist Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. U.K. Opioids Agonist Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Italy Opioids Agonist Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Russia Opioids Agonist Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Nordic Countries Opioids Agonist Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Opioids Agonist Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Opioids Agonist Drugs Market Share by Region (2020-2031)
Figure 36. China Opioids Agonist Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Japan Opioids Agonist Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. South Korea Opioids Agonist Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Opioids Agonist Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. India Opioids Agonist Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Australia Opioids Agonist Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Opioids Agonist Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Opioids Agonist Drugs Market Share by Country (2020-2031)
Figure 44. Mexico Opioids Agonist Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Brazil Opioids Agonist Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Opioids Agonist Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Opioids Agonist Drugs Market Share by Country (2020-2031)
Figure 48. Turkey Opioids Agonist Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Opioids Agonist Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. UAE Opioids Agonist Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Purdue Pharma Revenue Growth Rate in Opioids Agonist Drugs Business (2020-2025)
Figure 52. Titan pharmaceuticals Revenue Growth Rate in Opioids Agonist Drugs Business (2020-2025)
Figure 53. Boehringer Ingelheim Revenue Growth Rate in Opioids Agonist Drugs Business (2020-2025)
Figure 54. Janssen Pharmaceuticals, Inc Revenue Growth Rate in Opioids Agonist Drugs Business (2020-2025)
Figure 55. Sanofi Revenue Growth Rate in Opioids Agonist Drugs Business (2020-2025)
Figure 56. Sun Pharmaceuticals Revenue Growth Rate in Opioids Agonist Drugs Business (2020-2025)
Figure 57. Mallinckrodt Pharmaceuticals Revenue Growth Rate in Opioids Agonist Drugs Business (2020-2025)
Figure 58. Egalet Corporation Revenue Growth Rate in Opioids Agonist Drugs Business (2020-2025)
Figure 59. Endo Pharmaceuticals Inc. Revenue Growth Rate in Opioids Agonist Drugs Business (2020-2025)
Figure 60. Allergan, Plc Revenue Growth Rate in Opioids Agonist Drugs Business (2020-2025)
Figure 61. Pfizer Inc Revenue Growth Rate in Opioids Agonist Drugs Business (2020-2025)
Figure 62. Johnson & Johnson Services, Inc. Revenue Growth Rate in Opioids Agonist Drugs Business (2020-2025)
Figure 63. Hikma Pharmaceuticals PLC Revenue Growth Rate in Opioids Agonist Drugs Business (2020-2025)
Figure 64. Grünenthal Revenue Growth Rate in Opioids Agonist Drugs Business (2020-2025)
Figure 65. AbbVie Inc. Revenue Growth Rate in Opioids Agonist Drugs Business (2020-2025)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Table 1. Global Opioids Agonist Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Codeine
Table 3. Key Players of Fentanyl
Table 4. Key Players of Meperidine
Table 5. Key Players of Methadone
Table 6. Key Players of Morphine
Table 7. Key Players of Hydrocodone
Table 8. Global Opioids Agonist Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Opioids Agonist Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Opioids Agonist Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 11. Global Opioids Agonist Drugs Market Share by Region (2020-2025)
Table 12. Global Opioids Agonist Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 13. Global Opioids Agonist Drugs Market Share by Region (2026-2031)
Table 14. Opioids Agonist Drugs Market Trends
Table 15. Opioids Agonist Drugs Market Drivers
Table 16. Opioids Agonist Drugs Market Challenges
Table 17. Opioids Agonist Drugs Market Restraints
Table 18. Global Opioids Agonist Drugs Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Opioids Agonist Drugs Market Share by Players (2020-2025)
Table 20. Global Top Opioids Agonist Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioids Agonist Drugs as of 2024)
Table 21. Ranking of Global Top Opioids Agonist Drugs Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Opioids Agonist Drugs Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Opioids Agonist Drugs, Headquarters and Area Served
Table 24. Global Key Players of Opioids Agonist Drugs, Product and Application
Table 25. Global Key Players of Opioids Agonist Drugs, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Opioids Agonist Drugs Market Size by Type (2020-2025) & (US$ Million)
Table 28. Global Opioids Agonist Drugs Revenue Market Share by Type (2020-2025)
Table 29. Global Opioids Agonist Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 30. Global Opioids Agonist Drugs Revenue Market Share by Type (2026-2031)
Table 31. Global Opioids Agonist Drugs Market Size by Application (2020-2025) & (US$ Million)
Table 32. Global Opioids Agonist Drugs Revenue Market Share by Application (2020-2025)
Table 33. Global Opioids Agonist Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 34. Global Opioids Agonist Drugs Revenue Market Share by Application (2026-2031)
Table 35. North America Opioids Agonist Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. North America Opioids Agonist Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 37. North America Opioids Agonist Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 38. Europe Opioids Agonist Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 39. Europe Opioids Agonist Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 40. Europe Opioids Agonist Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 41. Asia-Pacific Opioids Agonist Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 42. Asia-Pacific Opioids Agonist Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 43. Asia-Pacific Opioids Agonist Drugs Market Size by Region (2026-2031) & (US$ Million)
Table 44. Latin America Opioids Agonist Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Latin America Opioids Agonist Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 46. Latin America Opioids Agonist Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 47. Middle East & Africa Opioids Agonist Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 48. Middle East & Africa Opioids Agonist Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 49. Middle East & Africa Opioids Agonist Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 50. Purdue Pharma Company Details
Table 51. Purdue Pharma Business Overview
Table 52. Purdue Pharma Opioids Agonist Drugs Product
Table 53. Purdue Pharma Revenue in Opioids Agonist Drugs Business (2020-2025) & (US$ Million)
Table 54. Purdue Pharma Recent Development
Table 55. Titan pharmaceuticals Company Details
Table 56. Titan pharmaceuticals Business Overview
Table 57. Titan pharmaceuticals Opioids Agonist Drugs Product
Table 58. Titan pharmaceuticals Revenue in Opioids Agonist Drugs Business (2020-2025) & (US$ Million)
Table 59. Titan pharmaceuticals Recent Development
Table 60. Boehringer Ingelheim Company Details
Table 61. Boehringer Ingelheim Business Overview
Table 62. Boehringer Ingelheim Opioids Agonist Drugs Product
Table 63. Boehringer Ingelheim Revenue in Opioids Agonist Drugs Business (2020-2025) & (US$ Million)
Table 64. Boehringer Ingelheim Recent Development
Table 65. Janssen Pharmaceuticals, Inc Company Details
Table 66. Janssen Pharmaceuticals, Inc Business Overview
Table 67. Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Product
Table 68. Janssen Pharmaceuticals, Inc Revenue in Opioids Agonist Drugs Business (2020-2025) & (US$ Million)
Table 69. Janssen Pharmaceuticals, Inc Recent Development
Table 70. Sanofi Company Details
Table 71. Sanofi Business Overview
Table 72. Sanofi Opioids Agonist Drugs Product
Table 73. Sanofi Revenue in Opioids Agonist Drugs Business (2020-2025) & (US$ Million)
Table 74. Sanofi Recent Development
Table 75. Sun Pharmaceuticals Company Details
Table 76. Sun Pharmaceuticals Business Overview
Table 77. Sun Pharmaceuticals Opioids Agonist Drugs Product
Table 78. Sun Pharmaceuticals Revenue in Opioids Agonist Drugs Business (2020-2025) & (US$ Million)
Table 79. Sun Pharmaceuticals Recent Development
Table 80. Mallinckrodt Pharmaceuticals Company Details
Table 81. Mallinckrodt Pharmaceuticals Business Overview
Table 82. Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Product
Table 83. Mallinckrodt Pharmaceuticals Revenue in Opioids Agonist Drugs Business (2020-2025) & (US$ Million)
Table 84. Mallinckrodt Pharmaceuticals Recent Development
Table 85. Egalet Corporation Company Details
Table 86. Egalet Corporation Business Overview
Table 87. Egalet Corporation Opioids Agonist Drugs Product
Table 88. Egalet Corporation Revenue in Opioids Agonist Drugs Business (2020-2025) & (US$ Million)
Table 89. Egalet Corporation Recent Development
Table 90. Endo Pharmaceuticals Inc. Company Details
Table 91. Endo Pharmaceuticals Inc. Business Overview
Table 92. Endo Pharmaceuticals Inc. Opioids Agonist Drugs Product
Table 93. Endo Pharmaceuticals Inc. Revenue in Opioids Agonist Drugs Business (2020-2025) & (US$ Million)
Table 94. Endo Pharmaceuticals Inc. Recent Development
Table 95. Allergan, Plc Company Details
Table 96. Allergan, Plc Business Overview
Table 97. Allergan, Plc Opioids Agonist Drugs Product
Table 98. Allergan, Plc Revenue in Opioids Agonist Drugs Business (2020-2025) & (US$ Million)
Table 99. Allergan, Plc Recent Development
Table 100. Pfizer Inc Company Details
Table 101. Pfizer Inc Business Overview
Table 102. Pfizer Inc Opioids Agonist Drugs Product
Table 103. Pfizer Inc Revenue in Opioids Agonist Drugs Business (2020-2025) & (US$ Million)
Table 104. Pfizer Inc Recent Development
Table 105. Johnson & Johnson Services, Inc. Company Details
Table 106. Johnson & Johnson Services, Inc. Business Overview
Table 107. Johnson & Johnson Services, Inc. Opioids Agonist Drugs Product
Table 108. Johnson & Johnson Services, Inc. Revenue in Opioids Agonist Drugs Business (2020-2025) & (US$ Million)
Table 109. Johnson & Johnson Services, Inc. Recent Development
Table 110. Hikma Pharmaceuticals PLC Company Details
Table 111. Hikma Pharmaceuticals PLC Business Overview
Table 112. Hikma Pharmaceuticals PLC Opioids Agonist Drugs Product
Table 113. Hikma Pharmaceuticals PLC Revenue in Opioids Agonist Drugs Business (2020-2025) & (US$ Million)
Table 114. Hikma Pharmaceuticals PLC Recent Development
Table 115. Grünenthal Company Details
Table 116. Grünenthal Business Overview
Table 117. Grünenthal Opioids Agonist Drugs Product
Table 118. Grünenthal Revenue in Opioids Agonist Drugs Business (2020-2025) & (US$ Million)
Table 119. Grünenthal Recent Development
Table 120. AbbVie Inc. Company Details
Table 121. AbbVie Inc. Business Overview
Table 122. AbbVie Inc. Opioids Agonist Drugs Product
Table 123. AbbVie Inc. Revenue in Opioids Agonist Drugs Business (2020-2025) & (US$ Million)
Table 124. AbbVie Inc. Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
Table 128. Authors List of This Report
List of Figures
Figure 1. Opioids Agonist Drugs Picture
Figure 2. Global Opioids Agonist Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Opioids Agonist Drugs Market Share by Type: 2024 VS 2031
Figure 4. Codeine Features
Figure 5. Fentanyl Features
Figure 6. Meperidine Features
Figure 7. Methadone Features
Figure 8. Morphine Features
Figure 9. Hydrocodone Features
Figure 10. Global Opioids Agonist Drugs Market Size by Application (2020-2031) & (US$ Million)
Figure 11. Global Opioids Agonist Drugs Market Share by Application: 2024 VS 2031
Figure 12. Pain Management Case Studies
Figure 13. Cough Treatment Case Studies
Figure 14. Diarrhea Treatment Case Studies
Figure 15. Opioids Agonist Drugs Report Years Considered
Figure 16. Global Opioids Agonist Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global Opioids Agonist Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Opioids Agonist Drugs Market Share by Region: 2024 VS 2031
Figure 19. Global Opioids Agonist Drugs Market Share by Players in 2024
Figure 20. Global Top Opioids Agonist Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioids Agonist Drugs as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by Opioids Agonist Drugs Revenue in 2024
Figure 22. North America Opioids Agonist Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. North America Opioids Agonist Drugs Market Share by Country (2020-2031)
Figure 24. United States Opioids Agonist Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Canada Opioids Agonist Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Opioids Agonist Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Opioids Agonist Drugs Market Share by Country (2020-2031)
Figure 28. Germany Opioids Agonist Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. France Opioids Agonist Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. U.K. Opioids Agonist Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Italy Opioids Agonist Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Russia Opioids Agonist Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Nordic Countries Opioids Agonist Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Opioids Agonist Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Opioids Agonist Drugs Market Share by Region (2020-2031)
Figure 36. China Opioids Agonist Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Japan Opioids Agonist Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. South Korea Opioids Agonist Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Opioids Agonist Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. India Opioids Agonist Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Australia Opioids Agonist Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Opioids Agonist Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Opioids Agonist Drugs Market Share by Country (2020-2031)
Figure 44. Mexico Opioids Agonist Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Brazil Opioids Agonist Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Opioids Agonist Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Opioids Agonist Drugs Market Share by Country (2020-2031)
Figure 48. Turkey Opioids Agonist Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Opioids Agonist Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. UAE Opioids Agonist Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Purdue Pharma Revenue Growth Rate in Opioids Agonist Drugs Business (2020-2025)
Figure 52. Titan pharmaceuticals Revenue Growth Rate in Opioids Agonist Drugs Business (2020-2025)
Figure 53. Boehringer Ingelheim Revenue Growth Rate in Opioids Agonist Drugs Business (2020-2025)
Figure 54. Janssen Pharmaceuticals, Inc Revenue Growth Rate in Opioids Agonist Drugs Business (2020-2025)
Figure 55. Sanofi Revenue Growth Rate in Opioids Agonist Drugs Business (2020-2025)
Figure 56. Sun Pharmaceuticals Revenue Growth Rate in Opioids Agonist Drugs Business (2020-2025)
Figure 57. Mallinckrodt Pharmaceuticals Revenue Growth Rate in Opioids Agonist Drugs Business (2020-2025)
Figure 58. Egalet Corporation Revenue Growth Rate in Opioids Agonist Drugs Business (2020-2025)
Figure 59. Endo Pharmaceuticals Inc. Revenue Growth Rate in Opioids Agonist Drugs Business (2020-2025)
Figure 60. Allergan, Plc Revenue Growth Rate in Opioids Agonist Drugs Business (2020-2025)
Figure 61. Pfizer Inc Revenue Growth Rate in Opioids Agonist Drugs Business (2020-2025)
Figure 62. Johnson & Johnson Services, Inc. Revenue Growth Rate in Opioids Agonist Drugs Business (2020-2025)
Figure 63. Hikma Pharmaceuticals PLC Revenue Growth Rate in Opioids Agonist Drugs Business (2020-2025)
Figure 64. Grünenthal Revenue Growth Rate in Opioids Agonist Drugs Business (2020-2025)
Figure 65. AbbVie Inc. Revenue Growth Rate in Opioids Agonist Drugs Business (2020-2025)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Outdoor Shed Market Research Report 2025
Sep 09, 25
Global Residential Outdoor Cabinet Market Research Report 2025
Sep 09, 25
Global Outdoor Storage Cabinet Market Research Report 2025
Sep 09, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232